Perioperativ heparin-bridging er sjældent indiceret

Jørn Dalsgaard Nielsen, Anna-Marie Bloch Münster, Steen Elkjær Husted

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Meta-analyses of cohort studies and a recent randomized, placebo-controlled study have shown that perioperative bridging of warfarin therapy with therapeutic doses of heparin results in a multi-fold increase in major bleeding but no reduction in the incidence of thromboembolism. It is time to reconsider heparin bridging: When is heparin bridging superfluous? When is prophylactic dosage indicated? And when is it safe to use therapeutic dosing?
Bidragets oversatte titelPerioperative heparin bridging is rarely indicated
OriginalsprogDansk
ArtikelnummerV12150952
TidsskriftUgeskrift for Laeger
Vol/bind178
Udgave nummer12
ISSN0041-5782
StatusUdgivet - 2016
Udgivet eksterntJa

Fingeraftryk Dyk ned i forskningsemnerne om 'Perioperativ heparin-bridging er sjældent indiceret'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater